documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
209 rows where agency_id = "DEA" and posted_year = 2025 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 4
- Notice 151
- Supporting & Related Material 27
- Rule 19
- Proposed Rule 12
posted_year 1
- 2025 · 209 ✖
agency_id 1
- DEA · 209 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEA-2023-0029-41937 | DEA | Telemedicine Prescribing of Controlled Substances (DEA407) DEA-2023-0029 | Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications | Rule | 2025-12-31T05:00:00Z | 2025 | 12 | 2025-12-31T05:00:00Z | 2026-01-13T03:01:01Z | 2025-24123 | 0 | 0 | 09000064b9113f32 | ||
| DEA-2023-0147-0004 | DEA | Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I (DEA1143) DEA-2023-0147 | Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I | Rule | 2025-12-23T05:00:00Z | 2025 | 12 | 2025-12-23T05:00:00Z | 2026-01-06T01:10:17Z | 2025-23717 | 0 | 0 | 09000064b91067de | ||
| DEA-2025-0952-0001 | DEA | Aveva Drug Delivery Systems, Inc. (DEA 1614) DEA-2025-0952 | 2025-23469 | Notice | 2025-12-19T05:00:00Z | 2025 | 12 | 2025-12-19T05:00:00Z | 2026-01-21T04:59:59Z | 2025-12-19T19:32:12Z | 2025-23469 | 0 | 0 | 09000064b90f4ec6 | |
| DEA-2025-0953-0001 | DEA | Janssen Pharmaceuticals, Inc. (DEA 1635) DEA-2025-0953 | 2025-23467 | Notice | 2025-12-19T05:00:00Z | 2025 | 12 | 2025-12-19T05:00:00Z | 2026-02-18T04:59:59Z | 2026-01-09T02:23:39Z | 2025-23467 | 0 | 0 | 09000064b90f4eeb | |
| DEA-2025-0951-0001 | DEA | Groff Health Inc. (DEA 1634) DEA-2025-0951 | 2025-23466 | Notice | 2025-12-19T05:00:00Z | 2025 | 12 | 2026-01-09T02:25:15Z | 0 | 1 | 09000064b90f4e72 | ||||
| DEA-2025-0954-0001 | DEA | Bright Green Corporation (DEA1612) DEA-2025-0954 | 2025-23468 | Notice | 2025-12-19T05:00:00Z | 2025 | 12 | 2025-12-19T05:00:00Z | 2026-01-21T04:59:59Z | 2025-12-19T19:57:02Z | 2025-23468 | 0 | 0 | 09000064b90f4f00 | |
| DEA-2025-0918-0003 | DEA | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604) DEA-2025-0918 | 251203 OASH to DEA draft letter 4 synthetic cannabinoids 8FA_signed 12032025 | Supporting & Related Material | 2025-12-18T05:00:00Z | 2025 | 12 | 2025-12-18T19:22:36Z | 0 | 0 | 09000064b90eed87 | ||||
| DEA-2025-0918-0005 | DEA | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604) DEA-2025-0918 | 4F-MDMB-BUTICA ADB-4en-PINACA 5F-EDMB-PICA MMB-FUBICA 8-Factor Analysis December 2025 DEA | Supporting & Related Material | 2025-12-18T05:00:00Z | 2025 | 12 | 2025-12-18T19:22:42Z | 0 | 0 | 09000064b90eed89 | ||||
| DEA-2025-0918-0004 | DEA | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604) DEA-2025-0918 | 4F-MDMB-BUTICA ADB-4en-PINACA 5F-EDMB-PICA MMB-FUBICA 8-Factor December 2025 HHS | Supporting & Related Material | 2025-12-18T05:00:00Z | 2025 | 12 | 2025-12-18T19:22:39Z | 0 | 0 | 09000064b90eed88 | ||||
| DEA-2025-0918-0002 | DEA | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604) DEA-2025-0918 | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I | Proposed Rule | 2025-12-16T05:00:00Z | 2025 | 12 | 2025-12-16T05:00:00Z | 2026-01-16T04:59:59Z | 2025-12-23T10:00:13Z | 2025-22963 | 0 | 0 | 09000064b90da711 | |
| DEA-2025-0918-0001 | DEA | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604) DEA-2025-0918 | Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act | Rule | 2025-12-16T05:00:00Z | 2025 | 12 | 2025-12-16T05:00:00Z | 2025-12-16T21:28:16Z | 2025-22960 | 0 | 0 | 09000064b90da7df | ||
| DEA-2025-0885-0003 | DEA | Schedules of Controlled Substances: Placement of Bromazolam in Schedule I (DEA1420) DEA-2025-0885 | HHS letter to DEA Bromazolam 07102025 | Supporting & Related Material | 2025-12-15T05:00:00Z | 2025 | 12 | 2025-12-15T20:47:51Z | 0 | 0 | 09000064b90d40f8 | ||||
| DEA-2025-0885-0002 | DEA | Schedules of Controlled Substances: Placement of Bromazolam in Schedule I (DEA1420) DEA-2025-0885 | HHS letter to DEA Bromazolam 06282024 | Supporting & Related Material | 2025-12-15T05:00:00Z | 2025 | 12 | 2025-12-15T20:47:46Z | 0 | 0 | 09000064b90d40f6 | ||||
| DEA-2025-0885-0001 | DEA | Schedules of Controlled Substances: Placement of Bromazolam in Schedule I (DEA1420) DEA-2025-0885 | Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I | Proposed Rule | 2025-12-15T05:00:00Z | 2025 | 12 | 2025-12-15T05:00:00Z | 2025-12-15T20:45:21Z | 2025-22763 | 0 | 0 | 09000064b90d3470 | ||
| DEA-2025-0885-0004 | DEA | Schedules of Controlled Substances: Placement of Bromazolam in Schedule I (DEA1420) DEA-2025-0885 | DEA 3-Factor Analysis Bromazolam December 2025 | Supporting & Related Material | 2025-12-15T05:00:00Z | 2025 | 12 | 2025-12-15T20:47:54Z | 0 | 0 | 09000064b90d40f7 | ||||
| DEA-2025-0852-0005 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) DEA-2025-0852 | HHS Letter to DEA cumyl-PEGACLONE_112024 | Supporting & Related Material | 2025-12-12T05:00:00Z | 2025 | 12 | 2025-12-13T02:46:04Z | 0 | 0 | 09000064b90cb028 | ||||
| DEA-2025-0852-0007 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) DEA-2025-0852 | HHS Letter to DEA cumyl-PEGACLONE_112024 | Supporting & Related Material | 2025-12-12T05:00:00Z | 2025 | 12 | 2025-12-13T02:50:33Z | 0 | 0 | 09000064b90cb02a | ||||
| DEA-2025-0852-0006 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) DEA-2025-0852 | CUMYL-PEGACLONE HHS 8 Factor Review | Supporting & Related Material | 2025-12-12T05:00:00Z | 2025 | 12 | 2025-12-13T02:50:28Z | 0 | 0 | 09000064b90cb029 | ||||
| DEA-2025-0852-0008 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) DEA-2025-0852 | CUMYL PEGACLONE DEA 8-Factor Analysis_1222025 | Supporting & Related Material | 2025-12-12T05:00:00Z | 2025 | 12 | 2025-12-13T02:50:36Z | 0 | 0 | 09000064b90cb02b | ||||
| DEA-2025-0852-0004 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) DEA-2025-0852 | CUMYL-PEGACLONE HHS 8 Factor Review | Supporting & Related Material | 2025-12-12T05:00:00Z | 2025 | 12 | 2025-12-13T02:46:02Z | 0 | 0 | 09000064b90cb027 | ||||
| DEA-2025-0852-0003 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) DEA-2025-0852 | CUMYL PEGACLONE DEA 8-Factor Analysis_1222025 | Supporting & Related Material | 2025-12-12T05:00:00Z | 2025 | 12 | 2025-12-13T02:45:59Z | 0 | 0 | 09000064b90cb026 | ||||
| DEA-2025-0555-0055 | DEA | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356) DEA-2025-0555 | Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I | Rule | 2025-12-11T05:00:00Z | 2025 | 12 | 2025-12-11T05:00:00Z | 2025-12-11T19:41:46Z | 2025-22540 | 0 | 0 | 09000064b90c55b5 | ||
| DEA-2025-0852-0002 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) DEA-2025-0852 | Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I | Rule | 2025-12-11T05:00:00Z | 2025 | 12 | 2025-12-11T05:00:00Z | 2025-12-11T19:46:09Z | 2025-22496 | 0 | 0 | 09000064b90c55b7 | ||
| DEA-2025-0852-0001 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) DEA-2025-0852 | Schedules of Controlled Substances: Placement of Cumyl-Pegaclone in Schedule I | Proposed Rule | 2025-12-11T05:00:00Z | 2025 | 12 | 2025-12-11T05:00:00Z | 2026-01-13T04:59:59Z | 2025-12-24T10:00:21Z | 2025-22495 | 0 | 0 | 09000064b90c30e5 | |
| DEA-2025-0820-0001 | DEA | Kinetochem, LLC (Bulk. Manuf) (DEA 1625) DEA-2025-0820 | 2025-21790 | Notice | 2025-12-03T05:00:00Z | 2025 | 12 | 2025-12-03T05:00:00Z | 2025-02-04T04:59:59Z | 2025-12-03T19:44:43Z | 2025-21790 | 0 | 0 | 09000064b90ab305 | |
| DEA-2025-0687-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Noramco DEA 1618 DEA-2025-0687 | 2025-21192 (1) | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2025-12-01T18:33:33Z | 0 | 0 | 09000064b90a17a3 | |||
| DEA-2025-0762-0001 | DEA | NSI Lab Solutions, LLC. (DEA 1608) DEA-2025-0762 | 2025-21180 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2025-12-27T04:59:59Z | 2025-12-01T23:13:28Z | 2025-21180 | 0 | 0 | 09000064b90a54c2 | |
| DEA-2025-0770-0001 | DEA | National Center for Natural Products Research (DEA 1621) DEA-2025-0770 | 2025-21190 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-27T04:59:59Z | 2025-12-02T00:40:21Z | 2025-21190 | 0 | 0 | 09000064b90a7f1d | |
| DEA-2025-0774-0001 | DEA | Invizyne Technologies, Inc. (DEA 1630) DEA-2025-0774 | 2025-21724 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-31T04:59:59Z | 2025-12-02T01:23:44Z | 2025-21724 | 0 | 0 | 09000064b90a8065 | |
| DEA-2025-0772-0001 | DEA | Irvine Labs (DEA 1627) DEA-2025-0772 | 2025-21187 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-27T04:59:59Z | 2025-12-02T01:09:04Z | 2025-21187 | 0 | 0 | 09000064b90a7fa4 | |
| DEA-2025-0763-0001 | DEA | VHG Labs DBA LGC Standards (DEA 1609) DEA-2025-0763 | 2025-21181 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2025-12-27T04:59:59Z | 2025-12-05T10:00:17Z | 2025-21181 | 0 | 0 | 09000064b90a54dc | |
| DEA-2025-0757-0001 | DEA | Irvine Labs (DEA 1616) DEA-2025-0757 | 2025-21175 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2025-12-27T04:59:59Z | 2025-12-01T21:24:06Z | 2025-21175 | 0 | 0 | 09000064b90a6a09 | |
| DEA-2025-0761-0001 | DEA | Caligor Coghlan Pharma Services (I) (DEA 1606) DEA-2025-0761 | 2025-21179 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2025-12-27T04:59:59Z | 2025-12-01T22:02:52Z | 2025-21179 | 0 | 0 | 09000064b90a67c5 | |
| DEA-2025-0769-0001 | DEA | Fisher Clinical Services, Inc. (DEA 1602) DEA-2025-0769 | 2025-21189 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2025-12-27T04:59:59Z | 2025-12-02T00:34:28Z | 2025-21189 | 0 | 0 | 09000064b90a7f00 | |
| DEA-2025-0768-0001 | DEA | Organix Chemistry Solutions, LLC (DEA 1624) DEA-2025-0768 | 2025-21186 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-27T04:59:59Z | 2025-12-02T00:15:42Z | 2025-21186 | 0 | 0 | 09000064b90a67c7 | |
| DEA-2025-0764-0001 | DEA | Groff NA Hemplex LLC (DEA 1610) DEA-2025-0764 | 2025-21182 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-27T04:59:59Z | 2025-12-01T23:36:37Z | 2025-21182 | 0 | 0 | 09000064b90a54df | |
| DEA-2025-0773-0001 | DEA | Invizyne Technologies, Inc. (DEA 1630) DEA-2025-0773 | 2025-21724 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-31T04:59:59Z | 2025-12-02T01:15:20Z | 2025-21724 | 0 | 0 | 09000064b90a7fc6 | |
| DEA-2025-0765-0001 | DEA | Cayman Chemical Company (DEA 1593) DEA-2025-0765 | 2025-21183 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-27T04:59:59Z | 2025-12-01T23:43:27Z | 2025-21183 | 0 | 0 | 09000064b90a814e | |
| DEA-2025-0753-0001 | DEA | Importer of Controlled Substances Application: Benuvia Operations, LLC (DEA 1619) DEA-2025-0753 | 2025-21173 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-11-26T05:00:00Z | 2025-12-27T04:59:59Z | 2025-12-01T20:28:41Z | 2025-21173 | 0 | 0 | 09000064b90a6905 | |
| DEA-2025-0760-0001 | DEA | Siegfried Grafton, Inc. (DEA 1601) DEA-2025-0760 | 2025-21178 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2025-12-27T04:59:59Z | 2025-12-01T21:55:42Z | 2025-21178 | 0 | 0 | 09000064b90a67c1 | |
| DEA-2025-0767-0001 | DEA | Siegfried Grafton, Inc. (DEA 1607) DEA-2025-0767 | 2025-21185 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-27T04:59:59Z | 2025-12-02T00:03:58Z | 2025-21185 | 0 | 0 | 09000064b90a7016 | |
| DEA-2025-0759-0001 | DEA | Organic Standards Solutions International, LLC (DEA 1617) DEA-2025-0759 | 2025-21176 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2025-12-27T04:59:59Z | 2025-12-01T21:42:35Z | 2025-21176 | 0 | 0 | 09000064b90a6788 | |
| DEA-2025-0720-0001 | DEA | Importer of Controlled Substances Application: Noramco DEA 1622 DEA-2025-0720 | 2025-21191 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2025-12-27T04:59:59Z | 2025-12-01T20:12:52Z | DEA-2025-0720 | 0 | 0 | 09000064b90a5893 | |
| DEA-2025-0756-0001 | DEA | Irvine Labs Inc. (M) (DEA 1615) DEA-2025-0756 | 2025-21174 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-27T04:59:59Z | 2025-12-01T21:10:37Z | 2025-21174 | 0 | 0 | 09000064b90a69de | |
| DEA-2025-0755-0001 | DEA | Irvine Labs Inc. (M) (DEA 1615) DEA-2025-0755 | 2025-21174 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-27T04:59:59Z | 2025-12-01T20:45:50Z | 2025-21174 | 0 | 0 | 09000064b90a6996 | |
| DEA-2025-0758-0001 | DEA | Organic Standards Solutions International, LLC (DEA 1617) DEA-2025-0758 | 2025-21176 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2025-12-27T04:59:59Z | 2025-12-01T21:33:01Z | DEA 2025-21176 | 0 | 0 | 09000064b90a6784 | |
| DEA-2025-0771-0001 | DEA | Benuvia Operations, LLC. (DEA 1629) DEA-2025-0771 | 2025-21720 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-31T04:59:59Z | 2025-12-02T00:50:08Z | 2025-21720 | 0 | 0 | 09000064b90a7f54 | |
| DEA-2025-0766-0001 | DEA | Eli-Elsohly Laboratories (DEA 1599) DEA-2025-0766 | 2025-21184 | Notice | 2025-12-01T05:00:00Z | 2025 | 12 | 2025-12-01T05:00:00Z | 2026-01-27T04:59:59Z | 2025-12-01T23:53:42Z | 2025-21184 | 0 | 0 | 09000064b90a81ba | |
| DEA-2025-0654-0001 | DEA | Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026 DEA-2025-0654 | Analysis for Proposed 2026 Aggregate Production Quotas and Assessment of Annual Needs | Notice | 2025-11-28T05:00:00Z | 2025 | 11 | 2025-11-28T05:00:00Z | 2025-12-16T04:59:59Z | 2025-12-16T10:00:28Z | 2025-21509 | 0 | 0 | 09000064b90a1b96 | |
| DEA-2024-0144-0006 | DEA | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246) DEA-2024-0144 | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I | Rule | 2025-11-17T05:00:00Z | 2025 | 11 | 2025-11-17T05:00:00Z | 2025-11-20T02:13:12Z | 2025-20004 | 0 | 0 | 09000064b9085a3d | ||
| DEA-2025-0522-0002 | DEA | Bulk Manufacturer of Controlled Substances Application: Cargill, Incorporated DEA1598 DEA-2025-0522 | 2025-19317 | Notice | 2025-10-31T04:00:00Z | 2025 | 10 | 2025-10-31T04:00:00Z | 2025-12-02T04:59:59Z | 2025-10-31T14:38:02Z | 2025-19317 | 0 | 0 | 09000064b905b0a2 | |
| DEA-2025-0588-0002 | DEA | Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I (DEA1494) DEA-2025-0588 | Seven benzimidazole opioids 811h no objection ASH to DEA 22Apr2025.AA | Supporting & Related Material | 2025-10-16T04:00:00Z | 2025 | 10 | 2025-10-17T03:33:17Z | 0 | 0 | 09000064b902eca3 | ||||
| DEA-2025-0588-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I (DEA1494) DEA-2025-0588 | Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I | Rule | 2025-10-15T04:00:00Z | 2025 | 10 | 2025-10-15T04:00:00Z | 2025-10-17T03:23:35Z | 2025-19542 | 0 | 0 | 09000064b901aa49 | ||
| DEA-2025-0555-0003 | DEA | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356) DEA-2025-0555 | 8FA MDMB-4en-PINACA | Supporting & Related Material | 2025-10-03T04:00:00Z | 2025 | 10 | 2025-10-03T22:46:34Z | 0 | 0 | 09000064b8ff1b92 | ||||
| DEA-2025-0555-0004 | DEA | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356) DEA-2025-0555 | SIGNED - OASH to DEA Ltr 8FA MDMB-PINACA.VAS | Supporting & Related Material | 2025-10-03T04:00:00Z | 2025 | 10 | 2025-10-03T22:46:38Z | 0 | 0 | 09000064b8ff1b94 | ||||
| DEA-2025-0555-0002 | DEA | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356) DEA-2025-0555 | MDMB-4en-PINACA 8F Oct 2025 | Supporting & Related Material | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-03T01:16:43Z | 0 | 0 | 09000064b8fefe68 | ||||
| DEA-2025-0558-0001 | DEA | Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction (DEA1111) DEA-2025-0558 | Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction | Rule | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-10-03T01:30:04Z | 2025-19292 | 0 | 0 | 09000064b8ff064c | ||
| DEA-2025-0555-0001 | DEA | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356) DEA-2025-0555 | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I | Proposed Rule | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-11-04T04:59:59Z | 2025-11-04T10:00:11Z | 2025-19348 | 0 | 0 | 09000064b8ff06ce | |
| DEA-2023-0016-0010 | DEA | Controlled Substances Ordering System Modernization (DEA732) DEA-2023-0016 | Controlled Substances Ordering System Modernization | Rule | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-10-03T01:31:47Z | 2025-19325 | 0 | 0 | 09000064b8ff074c | ||
| DEA-2025-0556-0001 | DEA | Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical DEA-2025-0556 | Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical | Rule | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-10-03T01:20:48Z | 2025-19349 | 0 | 0 | 09000064b8ff07c5 | ||
| DEA-2025-0557-0001 | DEA | Designation of P2P Methyl Glycidic Acid as a List I Chemical (DEA1395) DEA-2025-0557 | Designation of P2P Methyl Glycidic Acid as a List I Chemical | Proposed Rule | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-11-04T04:59:59Z | 2025-11-04T10:00:11Z | 2025-19384 | 0 | 0 | 09000064b8ff05d4 | |
| DEA-2025-0522-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Cargill, Incorporated DEA1598 DEA-2025-0522 | Bulk Manufacturer-Cargill Incorp(2025-19317)DEA1598 | Notice | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-12-02T04:59:59Z | 2025-10-02T22:46:29Z | 2025-19317 | 0 | 0 | 09000064b8fef93e | |
| DEA-2025-0489-0001 | DEA | Importer of Controlled Substances Application: Groff NA Hemplex LLC DEA1603 DEA-2025-0489 | Importer of Controlled-Groff NA Hemplex(2025-18901)DEA1603 | Notice | 2025-09-30T04:00:00Z | 2025 | 9 | 2025-09-30T04:00:00Z | 2025-10-31T03:59:59Z | 2025-09-30T16:13:02Z | 2025-18901 | 0 | 0 | 09000064b8fe6490 | |
| DEA-2025-0456-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Groff Health Inc DEA1600 DEA-2025-0456 | Bulk Manufacturer-Groff Health (2025-18244)DEA1600 | Notice | 2025-09-22T04:00:00Z | 2025 | 9 | 2025-09-22T04:00:00Z | 2025-11-22T04:59:59Z | 2025-11-20T10:00:15Z | 2025-18244 | 0 | 0 | 09000064b8fd1b53 | |
| DEA-2024-0120-1884 | DEA | Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025 DEA-2024-0120 | Adjustment to the Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for Conversion) for 2025 Pursuant to 21 U.S.C. 826(h) | Notice | 2025-09-19T04:00:00Z | 2025 | 9 | 2025-09-19T04:00:00Z | 2025-09-19T20:15:52Z | 0 | 0 | 09000064b8fbef33 | |||
| DEA-2024-0148-0006 | DEA | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457) DEA-2024-0148 | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I | Rule | 2025-09-18T04:00:00Z | 2025 | 9 | 2025-09-18T04:00:00Z | 2025-10-03T01:28:48Z | 2025-18103 | 0 | 0 | 09000064b8fb0ed1 | ||
| DEA-2025-0423-0001 | DEA | Importer of Controlled Substances Application: Catalent Greenville, Inc. DEA1597 DEA-2025-0423 | Importer of Controlled-Catalent Greenville Inc(2025-17819)DEA1597 | Notice | 2025-09-16T04:00:00Z | 2025 | 9 | 2025-09-16T04:00:00Z | 2025-10-17T03:59:59Z | 2025-09-16T16:07:31Z | 2025-17819 | 0 | 0 | 09000064b8f936b1 | |
| DEA-2025-0393-0001 | DEA | Importer of Controlled Substances Application: Fresenius Kabi USA, LLC DEA1594 DEA-2025-0393 | Importer of Controlled-Fresenius Kabi USA(2025-17583)DEA1594 | Notice | 2025-09-12T04:00:00Z | 2025 | 9 | 2025-09-12T04:00:00Z | 2025-10-15T03:59:59Z | 2025-09-12T16:30:55Z | 2025-17583 | 0 | 0 | 09000064b8f712f8 | |
| DEA-2025-0392-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc. DEA1590 DEA-2025-0392 | Bulk Manufacturer-Cambridge Isotope Lab(2025-17582)DEA1590 | Notice | 2025-09-12T04:00:00Z | 2025 | 9 | 2025-09-12T04:00:00Z | 2025-11-13T04:59:59Z | 2025-11-13T10:00:13Z | 2025-17582 | 0 | 0 | 09000064b8f70247 | |
| DEA-2025-0394-0001 | DEA | Importer of Controlled Substance Application: Fisher Clinical Services, Inc. DEA1595 DEA-2025-0394 | Importer of Controlled-Fisher Clinical Services(2025-17650)DEA1595 | Notice | 2025-09-12T04:00:00Z | 2025 | 9 | 2025-09-12T04:00:00Z | 2025-10-15T03:59:59Z | 2025-09-12T16:35:39Z | 2025-17650 | 0 | 0 | 09000064b8f712fc | |
| DEA-2025-0391-0001 | DEA | Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC DEA1592 DEA-2025-0391 | Importer of Controlled Substances-Catalent Pharma(2025-17581)DEA1592 | Notice | 2025-09-12T04:00:00Z | 2025 | 9 | 2025-09-12T04:00:00Z | 2025-10-15T03:59:59Z | 2025-09-12T16:19:47Z | 2025-17581 | 0 | 0 | 09000064b8f70246 | |
| DEA-2025-0390-0001 | DEA | Importer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc. DEA1591 DEA-2025-0390 | Importer of Controlled-Cambridge Isotope Labs(2025-17580)DEA1591 | Notice | 2025-09-12T04:00:00Z | 2025 | 9 | 2025-09-12T04:00:00Z | 2025-10-15T03:59:59Z | 2025-09-12T16:10:30Z | 2025-17580 | 0 | 0 | 09000064b8f730a1 | |
| DEA-2025-0357-0001 | DEA | Importer of Controlled Substances Application: Biopharmaceutical Research Company DEA1580 DEA-2025-0357 | Importer of Controlled-Biopharmaceutical Research(2025-17503)DEA1580 | Notice | 2025-09-11T04:00:00Z | 2025 | 9 | 2025-09-11T04:00:00Z | 2025-10-15T03:59:59Z | 2025-09-11T17:29:27Z | 2025-17503 | 0 | 0 | 09000064b8f6be50 | |
| DEA-2025-0324-0001 | DEA | Importer of Controlled Substances Application: VA Cooperative Studies Program DEA1561 DEA-2025-0324 | Importer of Controlled-VA Cooperative Studies(2025-17210) DEA1561 | Notice | 2025-09-08T04:00:00Z | 2025 | 9 | 2025-09-08T04:00:00Z | 2025-10-09T03:59:59Z | 2025-10-09T09:00:21Z | 2025-17210 | 0 | 0 | 09000064b8f52549 | |
| DEA-2025-0291-0001 | DEA | Importer of Controlled Substances Application: Cambrex High Point, Inc. DEA1583 DEA-2025-0291 | Importer of Controlled-Cambrex High Point(2025-16002)DEA1583 | Notice | 2025-08-21T04:00:00Z | 2025 | 8 | 2025-08-21T04:00:00Z | 2025-09-23T03:59:59Z | 2025-08-21T16:43:49Z | 2025-16002 | 0 | 0 | 09000064b8f0b5ab | |
| DEA-2025-0292-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc. DEA1585 DEA-2025-0292 | Bulk Manufacturer-Cambrex High Point(2025-16003)DEA1585 | Notice | 2025-08-21T04:00:00Z | 2025 | 8 | 2025-08-21T04:00:00Z | 2025-10-21T03:59:59Z | 2025-09-03T09:00:19Z | 2025-16003 | 0 | 0 | 09000064b8f0b5b0 | |
| DEA-2025-0294-0001 | DEA | Importer of Controlled Substances Application: Cambrex Charles City DEA1587 DEA-2025-0294 | Importer of Controlled Sub-Cambrex Charles City(2025-16005)DEA1587 | Notice | 2025-08-21T04:00:00Z | 2025 | 8 | 2025-08-21T04:00:00Z | 2025-09-23T03:59:59Z | 2025-08-21T16:58:14Z | 2025-16005 | 0 | 0 | 09000064b8f0b5bb | |
| DEA-2025-0296-0001 | DEA | Importer of Controlled Substances Application: Vici Health Sciences, LLC DEA1588 DEA-2025-0296 | Importer of Controlled-Vici Health Sciences(2025-16006)DEA1588 | Notice | 2025-08-21T04:00:00Z | 2025 | 8 | 2025-08-21T04:00:00Z | 2025-09-23T03:59:59Z | 2025-08-21T17:07:24Z | 2025-16006 | 0 | 0 | 09000064b8f0b5c9 | |
| DEA-2025-0293-0001 | DEA | Importer of Controlled Substances Application: Catalent CTS, LLC DEA1586 DEA-2025-0293 | Importer of Controlled-Catalent CTS(2025-16004)DEA1586 | Notice | 2025-08-21T04:00:00Z | 2025 | 8 | 2025-08-21T04:00:00Z | 2025-09-23T03:59:59Z | 2025-08-21T16:53:14Z | 2025-16004 | 0 | 0 | 09000064b8f0b5b4 | |
| DEA-2025-0295-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Continuus Pharmaceuticals DEA1589 DEA-2025-0295 | Bulk Manufacturer-Continuus Pharma(2025-16007)DEA1589 | Notice | 2025-08-21T04:00:00Z | 2025 | 8 | 2025-08-21T04:00:00Z | 2025-10-21T03:59:59Z | 2025-08-21T17:02:58Z | 2025-16007 | 0 | 0 | 09000064b8f0b5c1 | |
| DEA-2024-0118-0003 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I (DEA1337) DEA-2024-0118 | Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I | Rule | 2025-08-15T04:00:00Z | 2025 | 8 | 2025-08-15T04:00:00Z | 2025-08-15T17:55:48Z | 2025-15566 | 0 | 0 | 09000064b8f008ec | ||
| DEA-2025-0267-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC DEA1584 DEA-2025-0267 | Bulk Manufacturer-Benuvia Operations(2025-15279)DEA1584 | Notice | 2025-08-12T04:00:00Z | 2025 | 8 | 2025-08-12T04:00:00Z | 2025-10-15T03:59:59Z | 2025-08-12T16:23:23Z | 2025-15279 | 0 | 0 | 09000064b8ef7540 | |
| DEA-2025-0266-0001 | DEA | Importer of Controlled Substances Application: Chattem Chemicals DEA1577 DEA-2025-0266 | Importer of Controlled-Chattem Chemicals(2025-15159)DEA1577 | Notice | 2025-08-11T04:00:00Z | 2025 | 8 | 2025-08-11T04:00:00Z | 2025-09-11T03:59:59Z | 2025-09-11T09:00:21Z | 2025-15159 | 0 | 0 | 09000064b8ef5ec3 | |
| DEA-2025-0265-0001 | DEA | Importer of Controlled Substances Application: Benuvia Operations, LLC DEA1576 DEA-2025-0265 | Importer of Controlled-Benuvia Operations(2025-15158)DEA1576 | Notice | 2025-08-11T04:00:00Z | 2025 | 8 | 2025-08-11T04:00:00Z | 2025-09-11T03:59:59Z | 2025-09-11T09:00:21Z | 2025-15158 | 0 | 0 | 09000064b8ef5ec0 | |
| DEA-2025-0262-0001 | DEA | Importer of Controlled Substances Application: Curia New York Inc DEA1574 DEA-2025-0262 | Importer of Controlled-Curia New York(2025-15156)DEA1574 | Notice | 2025-08-11T04:00:00Z | 2025 | 8 | 2025-08-11T04:00:00Z | 2025-09-11T03:59:59Z | 2025-09-11T09:00:21Z | 2025-15156 | 0 | 0 | 09000064b8ef5e2f | |
| DEA-2025-0261-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals DEA1581 DEA-2025-0261 | Bulk Manufacturer-Chattam Chemicals(2025-15161)DEA1581 | Notice | 2025-08-11T04:00:00Z | 2025 | 8 | 2025-08-11T04:00:00Z | 2025-10-11T03:59:59Z | 2025-08-11T17:13:34Z | 2025-15161 | 0 | 0 | 09000064b8ef5e03 | |
| DEA-2025-0264-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City DEA1575 DEA-2025-0264 | Bulk Manufacturer-Cambrex Charles(2025-15157)DEA1575 | Notice | 2025-08-11T04:00:00Z | 2025 | 8 | 2025-08-11T04:00:00Z | 2025-10-11T03:59:59Z | 2025-08-11T17:26:54Z | 2025-15157 | 0 | 0 | 09000064b8ef5e8d | |
| DEA-2025-0259-0001 | DEA | Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc DEA1573 DEA-2025-0259 | Importer of Controlled-Galephar Pharma(2025-15155)DEA1573 | Notice | 2025-08-11T04:00:00Z | 2025 | 8 | 2025-08-11T04:00:00Z | 2025-09-11T03:59:59Z | 2025-08-11T17:04:37Z | 2025-15155 | 0 | 0 | 09000064b8ef3bef | |
| DEA-2025-0263-0001 | DEA | Importer of Controlled Substances Application: Experic LLC DEA1579 DEA-2025-0263 | Importer of Controlled-Experic LLC(2025-15160)DEA1579 | Notice | 2025-08-11T04:00:00Z | 2025 | 8 | 2025-08-11T04:00:00Z | 2025-09-11T03:59:59Z | 2025-08-11T17:22:16Z | 2025-15160 | 0 | 0 | 09000064b8ef5e87 | |
| DEA-2025-0260-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company DEA1582 DEA-2025-0260 | Bulk Manufacturer-Biopharmaceutical(2025-15162)DEA1582 | Notice | 2025-08-11T04:00:00Z | 2025 | 8 | 2025-08-11T04:00:00Z | 2025-10-11T03:59:59Z | 2025-08-11T17:09:15Z | 2025-15162 | 0 | 0 | 09000064b8ef5dfd | |
| DEA-2025-0258-0001 | DEA | Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc DEA1564 DEA-2025-0258 | Importer of Controlled-Veterans Pharma(2025-15153)DEA1564 | Notice | 2025-08-11T04:00:00Z | 2025 | 8 | 2025-08-11T04:00:00Z | 2025-09-11T03:59:59Z | 2025-09-11T09:00:20Z | 2025-15153 | 0 | 0 | 09000064b8ef3bed | |
| DEA-2025-0192-0003 | DEA | Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance (DEA1390) DEA-2025-0192 | Specific Listing for Dipentylone, A Currently Controlled Schedule I Substance | Rule | 2025-08-08T04:00:00Z | 2025 | 8 | 2025-08-08T04:00:00Z | 2025-09-10T04:16:28Z | 2025-15177 | 0 | 0 | 09000064b8ef0c9b | ||
| DEA-2025-0225-0001 | DEA | Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC DEA1572 DEA-2025-0225 | Bulk Manufacturer-ChemtosLLC(2025-15115)DEA1572 | Notice | 2025-08-08T04:00:00Z | 2025 | 8 | 2025-08-08T04:00:00Z | 2025-10-08T03:59:59Z | 2025-08-08T16:18:00Z | 2025-15115 | 0 | 0 | 09000064b8ef2433 | |
| DEA-2025-0192-0001 | DEA | Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance (DEA1390) DEA-2025-0192 | 2025-11462 | Notice | 2025-08-01T04:00:00Z | 2025 | 8 | 2025-08-01T04:00:00Z | 2025-08-02T00:45:56Z | 0 | 0 | 09000064b8ecca1d | |||
| DEA-2025-0192-0002 | DEA | Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance (DEA1390) DEA-2025-0192 | DEA-1494 Three Factor Analysis for Temporary Control of Seven Benzimidazole-Opioids | Supporting & Related Material | 2025-08-01T04:00:00Z | 2025 | 8 | 2025-08-02T00:46:00Z | 0 | 0 | 09000064b8ecca29 | ||||
| DEA-2022-0145-0008 | DEA | Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989) DEA-2022-0145 | DEA989 HHS 8-Factor Analysis | Supporting & Related Material | 2025-07-25T04:00:00Z | 2025 | 7 | 2025-07-25T21:33:08Z | 0 | 0 | 09000064b8ea2f07 | ||||
| DEA-2022-0145-0006 | DEA | Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989) DEA-2022-0145 | Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I | Proposed Rule | 2025-07-25T04:00:00Z | 2025 | 7 | 2025-07-25T04:00:00Z | 2025-08-26T03:59:59Z | 2025-08-21T09:01:13Z | 2025-14022 | 0 | 0 | 09000064b8e9caad | |
| DEA-2022-0145-0007 | DEA | Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989) DEA-2022-0145 | DEA989 DEA 8-Factor Analysis | Supporting & Related Material | 2025-07-25T04:00:00Z | 2025 | 7 | 2025-07-25T21:33:05Z | 0 | 0 | 09000064b8e9d6f4 | ||||
| DEA-2022-0145-0005 | DEA | Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989) DEA-2022-0145 | Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I | Rule | 2025-07-25T04:00:00Z | 2025 | 7 | 2025-07-25T04:00:00Z | 2025-07-25T16:18:35Z | 2025-14037 | 0 | 0 | 09000064b8e9cab5 | ||
| DEA-2025-0161-0001 | DEA | Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services DEA1568 DEA-2025-0161 | Importer of Controlled-AndersonBrecon(2025-13451)DEA1568 | Notice | 2025-07-17T04:00:00Z | 2025 | 7 | 2025-07-17T04:00:00Z | 2025-08-19T03:59:59Z | 2025-07-17T16:47:52Z | 2025-13451 | 0 | 0 | 09000064b8e804b7 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;